STOCK TITAN

InfuSystem Holdings, Inc. - INFU STOCK NEWS

Welcome to our dedicated page for InfuSystem Holdings news (Ticker: INFU), a resource for investors and traders seeking the latest updates and insights on InfuSystem Holdings stock.

InfuSystem Holdings, Inc. (NYSE American: INFU) is a growing healthcare service provider specializing in delivering infusion pumps and related products and services to patients across the United States and Canada. The company is headquartered in Rochester Hills, Michigan, and operates from five strategically located facilities to ensure comprehensive coverage. InfuSystem facilitates outpatient care through a two-platform model: Patient Services and Device Solutions.

Patient Services offers a last-mile solution for clinic-to-home healthcare. This segment includes Oncology, Pain Management, Wound Therapy, and Lymphedema services. It focuses on delivering complex durable medical equipment directly to patients, ensuring they receive continuous care at home or other non-hospital settings.

Device Solutions supports the Patient Services platform by providing direct payer rentals, pump and consumable sales, and biomedical services and repair. This segment's goal is to enhance service orientation and secure additional business from its direct payer clients.

InfuSystem's innovative approach and strategic partnerships have made it a leader in the healthcare service sector. Recently, the company announced a sales and marketing partnership with Dignitana AB, a leader in scalp cooling technology. This collaboration allows InfuSystem to offer the FDA-cleared DigniCap Scalp Cooling System to help minimize hair loss for cancer patients undergoing chemotherapy. This partnership highlights InfuSystem's commitment to enhancing patient care and expanding its product offerings.

InfuSystem boasts a robust financial position, underpinned by its diversified service offerings and strong market presence. The company continues to explore new opportunities to grow and enhance its service delivery, ensuring that it remains at the forefront of the healthcare industry.

Rhea-AI Summary

InfuSystem Holdings, Inc. (NYSE American: INFU), a leading national health care service provider, has announced it will release its second quarter 2024 financial results on Thursday, August 8, 2024, before the market opens. The company will host a conference call at 9:00 a.m. Eastern Time on the same day to discuss the results.

InfuSystem operates under a two-platform model: Patient Services, which includes Oncology, Pain Management, and Wound Therapy businesses, and Device Solutions, which supports Patient Services and focuses on direct payer clients. The company provides outpatient care solutions for durable medical equipment manufacturers and health care providers, with a focus on clinic-to-home healthcare for complex treatments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.69%
Tags
conferences earnings
-
Rhea-AI Summary

InfuSystem will present at the Sidoti Small Cap Virtual Investor Conference on June 12, 2024, at 8:30 a.m. Eastern Time. The conference will feature presentations from CEO Richard DiIorio, CFO Barry Steele, and COO Carrie Lachance. Investors can access the live webcast and replay on InfuSystem's website. Additionally, the management will host virtual one-on-one meetings throughout the day. InfuSystem, based in Rochester Hills, Michigan, provides outpatient care for durable medical equipment through two main platforms: Patient Services and Device Solutions. The company operates several Centers of Excellence in the USA and Canada.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.43%
Tags
conferences
-
Rhea-AI Summary

InfuSystem, a national healthcare service provider, announced a $20 million stock repurchase program authorized by its Board of Directors. This program extends through June 30, 2026, and replaces the previous authorization expiring June 30, 2024, under which 550 thousand shares were repurchased for $6.2 million. The new program highlights confidence in the company’s operations, financial strength, and future outlook, allowing flexible share repurchases under favorable conditions. CEO Richard DiIorio emphasized the company’s commitment to strategic investments for sustainable growth while considering opportunistic buybacks.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.16%
Tags
buyback
Rhea-AI Summary

InfuSystem reported record net revenues of $32.0 million in the first quarter of 2024, representing a 5% growth from the prior year. The gross profit increased by 10%, with a gross margin of 51.5%. Adjusted EBITDA decreased by 9% compared to the prior year. The company's liquidity totaled $45.4 million as of March 31, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.79%
Tags
-
Rhea-AI Summary

InfuSystem Holdings, Inc. (NYSE American: INFU) will report first quarter 2024 financial results on May 9, 2024. The company will conduct a conference call at 9:00 a.m. Eastern Time to discuss the results. InfuSystem is a leading national health care service provider, offering outpatient care for durable medical equipment manufacturers and health care providers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.35%
Tags
conferences earnings
-
Rhea-AI Summary
InfuSystem Holdings, Inc. receives notice of non-compliance from NYSE American due to delayed filing of Annual Report, cites issues with expense classification and ASC 842 adoption. Company granted Initial Cure Period of six months to file Delinquent Report with SEC to avoid delisting.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.09%
Tags
none
Rhea-AI Summary
InfuSystem Holdings, Inc. reports a successful financial year in 2023 with record net revenues of $125.8 million, a 14% increase from 2022. Patient Services Revenue reached $76.5 million, while Device Solutions Revenue was $49.2 million, showing increases of 11% and 20% respectively. Adjusted EBITDA saw an 8% increase, with a five-year CAGR of 13% for Net Revenues and 10% for Adjusted EBITDA.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.25%
Tags
-
Rhea-AI Summary
InfuSystem Holdings, Inc. (INFU) will release its preliminary fourth quarter and full year 2023 financial results on March 14, 2024, before the market opens. A conference call will be held at 9:00 a.m. Eastern Time on the same day to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.75%
Tags
conferences earnings
-
Rhea-AI Summary
InfuSystem Holdings, Inc. (NYSE American: INFU) is a leading national healthcare service provider, facilitating outpatient care for durable medical equipment manufacturers and healthcare providers. The company's CEO, CFO, and President will present at the Sidoti Small-Cap Virtual Investor Conference on December 6, 2023. A webcast and replay of the presentation will be available on the company's website. Investors can arrange one-on-one meetings with management by contacting the conference representative or Lytham Partners.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1%
Tags
conferences
Rhea-AI Summary
INFU - InfuSystem Holdings, Inc. to Participate in Craig-Hallum’s 14th Annual Alpha Select Conference on November 16, 2023 - InfuSystem, a leading national health care service provider, will have its CEO, CFO, and President participate in the conference at the Sheraton New York Times Square. Investors can arrange virtual one-on-one meetings by contacting Craig-Hallum or Lytham Partners.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.12%
Tags
conferences

FAQ

What is the current stock price of InfuSystem Holdings (INFU)?

The current stock price of InfuSystem Holdings (INFU) is $8.91 as of December 13, 2024.

What is the market cap of InfuSystem Holdings (INFU)?

The market cap of InfuSystem Holdings (INFU) is approximately 190.7M.

What services does InfuSystem Holdings, Inc. provide?

InfuSystem provides infusion pumps and related services to patients at home, in oncology clinics, ambulatory surgery centers, and other care sites.

What are the two platforms of InfuSystem's services?

InfuSystem operates through Patient Services, which includes Oncology, Pain Management, and Wound Therapy, and Device Solutions, which provides rentals, sales, and biomedical services.

Where is InfuSystem Holdings, Inc. headquartered?

InfuSystem Holdings, Inc. is headquartered in Rochester Hills, Michigan.

Who are InfuSystem's recent partners?

InfuSystem recently partnered with Dignitana AB to offer the DigniCap Scalp Cooling System, which helps minimize hair loss during chemotherapy.

What is the DigniCap Scalp Cooling System?

The DigniCap Scalp Cooling System is an FDA-cleared device designed to reduce hair loss in cancer patients undergoing chemotherapy.

What areas does InfuSystem serve?

InfuSystem serves patients across the United States and Canada.

What is the objective of the Patient Services platform?

The Patient Services platform aims to provide comprehensive clinic-to-home healthcare solutions, ensuring continuous care for patients using complex durable medical equipment.

How does the Device Solutions platform support InfuSystem?

Device Solutions enhances the Patient Services platform by offering direct payer rentals, pump and consumable sales, and biomedical services and repair.

What are InfuSystem's business segments?

InfuSystem's business segments include Oncology, Pain Management, Wound Therapy, and Lymphedema under Patient Services, and rentals, sales, and repair services under Device Solutions.

How does InfuSystem contribute to patient care?

InfuSystem ensures patients receive necessary medical equipment and services at home, improving their quality of life and enabling continuous treatment outside of hospital settings.

InfuSystem Holdings, Inc.

NYSE:INFU

INFU Rankings

INFU Stock Data

190.73M
20.01M
6.07%
78.98%
0.88%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
ROCHESTER HILLS